Consultant Pharmacists

1. Consultant Pharmacists Dr. Nicola Stoner Consultant Pharmacist, Cancer Services & Cancer Research UK Oxford Radcliffe Hospitals NHS Trust. Principal Visiting Fellow, The University of Reading. BOPA October 13th, 2007

2. Introduction • Background • Achievement of the role • Requirements for Consultant Posts • Competencies • Development of posts • Approval process • Examples of portfolio evidence • Consultant Pharmacist status - what does it achieve and what does it mean?

3. Background • “A Vision for Pharmacy in the New NHS” DOH 2003 • “Guidance for the Development of Consultant Pharmacist Posts” DOH 2005

4. Requirements for Consultant Posts • Expert Practice • Research, evaluation and service development • Education • Mentoring and overview of practice • Professional leadership and consultancy

5. Competencies of Consultant Pharmacists • Advanced and Consultant Level Competency Framework designed by the Competency Development and Evaluation Group (C0DEG) • Majority of competencies at Mastery for: • Expert professional practice • Building working relationships • Leadership • Majority of competencies at Excellence for: • Management • Education, training & development • Research & evaluation

6. How to Develop Consultant Posts • Transitional arrangements March 2005-March 2007 for existing posts • Using Consultant Pharmacist title • Pharmacists eligible for Consultant Pharmacist posts • Development of new posts The required elements and competencies of Consultant Pharmacist posts have to be demonstrated both within the host organisation and the wider health economy, preferably with links to higher education institutions.

7. Approval Process • Trust business case approval • Strategic Health Authority (SHA) approval • Written application • Approval of portfolio of evidence demonstrating competency requirements • Interview by external panel: • Chief Pharmacist • Pharmacist with appropriate expertise in the area of practice under consideration • SHA representative • Higher Education Institution (HEI) representative

8. Strategic Health Authority Application • Vision • Benefits and outcomes • Roles and responsibilities • Impact on patients, service, quality, wider health economy • Needs assessment & risk assessment • Strategic benefits • Funding and performance review arrangements • Competency assessment • Portfolio of evidence • Agenda for Change job profile

9. Examples of Evidence in Portfolio - Expert Practice • C.V. - 17 years oncology experience • Publications • Advisory panels • Presentations • Anti-emetics • Gene therapy • Non-medical prescribing • Electronic handbook • Electronic prescribing • Clinical trials

10. Examples of Evidence in Portfolio - Research, evaluation, service development • Investigator for clinical trials • Cancer Research UK clinical research unit • Research Committees (NCRN, CR-UK) • Postgraduate research project tutor • Posters, presentations, publications • Integrated & skill mixed cancer pharmacy service • Pre-assessment clinics • Training programs • Non-medical prescribing

11. Examples of Evidence in Portfolio -Education, mentoring, overview of practice • Honorary Principal Visiting Fellow, School of Pharmacy, The University of Reading • Tutor for postgraduate audits and research projects • University postgraduate course development & lectures • Development of training programs • National working groups

12. Examples of Evidence in Portfolio -Professional leadership & consultancy • Leadership within ORH and TVCN • Publications • Advisory boards • National working groups • Journal editorial board • Peer Reviewer • References from consultant colleagues • References from staff

13. What will Consultant Posts Achieve? • Retention of high level pharmaceutical expertise and skills in practice to improve patient care • Raise the profile of medicines management at a clinical level • Strengthen professional and clinical leadership • Improve strategic direction • Provide career opportunities

14. Consultant Pharmacist Status - what does it mean? • Development of Oxford Cancer Centre as a centre for training and excellence in cancer pharmacy • Role model and leader • Recruitment, retention, succession planning • Recognition of competency and achievements • Opportunities • Research collaboration • Education & training • Practice development

15. Summary • Background • Achievement of the role • Requirements for Consultant Posts • Competencies • Development of posts • Approval process • Examples of portfolio evidence • Consultant Pharmacist status - what does it achieve and what does it mean?

16. References • 1. Department of Health (2003). A Vision for Pharmacy in the New NHS. Available from URL: http://www.dh.gov.uk/publications • 2. Department of Health (2005). Guidance for the Development of Consultant Pharmacist Posts. Available from URL: http://www.dh.gov.uk/publications • 3. Connelly, D. (2007). Oncology consultant pharmacist appointed. The Pharmaceutical Journal. 278:541. • 4. Connelly, D. (2007) First Steps to Independent Prescribing. The Pharmaceutical Journal. 278:43-44. • 5. Connelly, D. (2007). Independent Prescribers Start Work. The Pharmaceutical Journal. 278:481-482. • 6. Connelly, D. (2007). Prescribers consolidate new skills. The Pharmaceutical Journal. 279:227-228.

17. Contact Details Dr Nicola Stoner Consultant Pharmacist, Cancer Services & Cancer Research UK Oxford Radcliffe Hospitals NHS Trust. Principal Visiting Fellow, The University of Reading Cancer Research UK Medical Oncology Unit The Churchill Oxford Radcliffe Hospitals NHS Trust Headington Oxford OX3 7LJ Tel. +44 (0)1865 226187 Fax. +44 (0)1865 226174 Email: nicola.stoner@orh.nhs.uk